Pulpotomy vs Root Canal Treatment for Teeth With Symptomatic Irreversible Pulpitis

Pulpitis - Irreversible Clinical Trial

Official title:

Pulpotomy vs Root Canal Treatment for Teeth With Symptomatic Irreversible Pulpitis

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT05964933
• Other study ID #: DSRB 2023/00044
• Status: Enrolling by invitation
• Phase: N/A
• Start date: July 11, 2023
• Est. completion date: December 2027

Study information

• Verified date: May 2023
• Source: National University Hospital, Singapore
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is a randomised controlled trial for complete pulpotomy as an alternative to root canal treatment for teeth with clinical diagnosis of symptomatic irreversible pulpitis (i.e. signs and symptoms indicative of irreversible pulpitis) conducted at the National University Centre for Oral Health Singapore (NUCOHS) Endodontic unit. Up to 70 teeth, 35 in each group, will be enrolled.

Clinical and radiographic outcome data will be collected and analysed, and a parallel cost-effectiveness analysis will also be undertaken to examine the potential costs and benefits of pulpotomy. A process evaluation will also be conducted to assess the acceptability of the intervention to both dentists and patients, while exploring the barriers and enablers to implementation.

Description:

Mature permanent teeth with deep caries/restorations and symptoms indicative of irreversible pulpitis (moderate to severe spontaneous lingering pain) will be included in the study. The teeth will be randomised to receive one of two treatments: RCT or complete pulpotomy (n=35 in each group).

Baseline clinical and radiographic data will be collected at the first visit. In addition, patients (or their guardians, if relevant) will be invited to complete the acceptability and willingness to pay questionnaires for health economics analysis at both the first visit and at 12 months from the date of completed treatment. Pain data will be collected via a pain diary after completion of treatment at days 3 and 7 post-treatment. Patients will be clinically and radiographically reviewed at 6 and 12 months from the date of completed treatment. Review clinical data collected will include the absence of pain (and details on the nature of pain, if relevant), tenderness to percussion and palpation, presence of a swelling or a sinus tract, pathological mobility, structural integrity of tooth, intact and non-defective restoration, and response to electric pulp testing (for the pulpotomy group only). Radiographic data collected will include the presence of periapical radiolucency, presence of inter-radicular radiolucency, presence of resorption, and presence of calcifications. The need for any further intervention (including details of any procedure) or any adverse events or unscheduled visits over the follow-up period will also be recorded.

Success will be defined as 1) the absence of pain indicative of irreversible pulpitis, 2) the absence of signs and symptoms indicative of acute or chronic periapical disease, and 3) the absence of radiographic evidence of failure including radiolucency or resorption. SPSS Statistical Package (IBM SPSS Statistics) will be used for all statistical analysis, with the significance level for all statistical tests set at p-value<0.05.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 70
• Est. completion date: December 2027
• Est. primary completion date: December 2026
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 12 Years and older

Eligibility

Inclusion Criteria:

• Patients aged 12 years or older

• Mature permanent tooth with deep caries/restorations

• Symptoms indicative of irreversible pulpitis (moderate to severe spontaneous lingering pain)

• Tooth is responsive to cold and electric pulp test (EPT) sensibility testing

• Tooth is restorable and can be adequately isolated during treatment

• One tooth (molar or premolar) per patient.

Exclusion Criteria:

• Teeth with active periodontal disease (pocket depth >5mm)

• Teeth indicated for elective root canal treatment for restorative purposes

• Teeth with apical periodontitis

• Patients with complex medical histories that may affect their caries experience and healing ability (immunocompromised, radiotherapy etc.)

• Patients who are unable to consent

• History of trauma to the tooth

• Presence of apical radiolucency

• Patients who are pregnant or breast-feeding

• Teeth with any evidence of purulence or excessive bleeding that cannot be controlled with a cotton pellet with 2-4% hypochlorite for 10 minutes

Related Conditions & MeSH terms

• Pulpitis
• Pulpitis - Irreversible

Intervention

Procedure:
• Complete Pulpotomy
Complete caries removal and excision of the entire coronal pulp to the level of the root canal orifices will be performed. After haemostasis, the pulp chamber will be filled with Biodentine® and a final direct restoration placed in 1 or 2 visits. If there is no bleeding from the exposed pulp, pulpectomy and root canal treatment will be performed instead, and the patient will be excluded from the study.
• Pulpectomy and Root Canal Treatment
After complete caries removal and pulp exposure, Pulpectomy will be performed to remove all pulp tissues. Conventional root canal treatment will be performed using rotary instrumentation followed by obturation with gutta percha and traditional sealers in 1 or 2 visits. A final restoration will be placed to ensure a good coronal seal, and this may include full coronal coverage restorations if clinically indicated.

Locations

Country	Name	City	State
Singapore	National University Hospital, Singapore	Singapore

Sponsors (1)

Lead Sponsor	Collaborator
National University Hospital, Singapore

Country where clinical trial is conducted

Singapore, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Composite measure is defined by the change from baseline pain and radiographic status at 6 months and again at 12 months.	Composite measure defined as: absence of pain indicative of irreversible pulpitis; absence of signs and symptoms indicative of acute or chronic periapical disease; absence of radiographic evidence of failure including radiolucency or resorption.	6, 12 months
Secondary	Numeric Rate Scale (NRS): minimum value = 0 (best outcome), maximum value = 10 (worst outcome)	A patient reported outcome of pain experienced and use of analgesia in the immediate post-operative period, collected through a Numeric Rating Scale (NRS).	3, 7 days
Secondary	Restoration: the restoration remains intact and adapts completely to the prepared cavity margins.	The presence of a structurally integral tooth with an intact, non-defective restoration.	6, 12 months
Secondary	A "yes" or "no" response when the Cold Test and Electric Pulp Test are applied on the treated tooth.	Positive sensibility response on electrical pulp test (EPT) for the Pulpotomy group only.	6, 12 months
Secondary	N5. Clinicians examine the treated tooth to determine if there is pathology that resulted from the treatment.	Absence of need for any further intervention during the follow-up period or any adverse event.	12 months
Secondary	Data to be collected include time spent on receiving the treatment, cost of treatment, and patients' willingness to pay for treatment.	A parallel process evaluation and health economics analysis will be completed using data collected from participants at baseline and at 12 months.	12 months
Secondary	Radiographic appearance of the dental pulp and its canal(s) at baseline will be compared to that at 12 months.	Radiographic evidence of pulp calcification in response to Pulpotomy (applicable to the Pulpotomy group only).	12, months